AJANTA PHARMA
Quarterly Results Analysis [Mar2025]
AJANTA PHARMA Quarterly Results
Consolidated | Mar2025 UnAudited |
Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,170 Cr | ₹1,146 Cr | ₹1,187 Cr | ₹1,145 Cr | ₹1,054 Cr | ₹1,105 Cr | ₹1,028 Cr | ₹1,021 Cr |
Expenses | ₹873 Cr | ₹825 Cr | ₹875 Cr | ₹815 Cr | ₹776 Cr | ₹791 Cr | ₹738 Cr | ₹750 Cr |
Operating Income | ₹297 Cr | ₹321 Cr | ₹311 Cr | ₹330 Cr | ₹278 Cr | ₹314 Cr | ₹291 Cr | ₹271 Cr |
Other Income | ₹18 Cr | ₹30 Cr | ₹19 Cr | ₹26 Cr | ₹36 Cr | ₹14 Cr | ₹21 Cr | ₹32 Cr |
Interest | ₹6 Cr | ₹8 Cr | ₹6 Cr | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹1 Cr |
Depreciation | ₹40 Cr | ₹36 Cr | ₹34 Cr | ₹34 Cr | ₹34 Cr | ₹34 Cr | ₹34 Cr | ₹33 Cr |
Profit Before Tax | ₹269 Cr | ₹307 Cr | ₹290 Cr | ₹322 Cr | ₹278 Cr | ₹291 Cr | ₹276 Cr | ₹269 Cr |
Profit After Tax | ₹225 Cr | ₹233 Cr | ₹216 Cr | ₹246 Cr | ₹203 Cr | ₹210 Cr | ₹195 Cr | ₹208 Cr |
EPS | ₹17.97 | ₹18.58 | ₹17.27 | ₹19.61 | ₹16.04 | ₹16.62 | ₹15.46 | ₹16.47 |
Industry Peers & Returns | 1W | 1M | 1Y |
AJANTA PHARMA | 4.1% | 1.6% | 13% |
SUN PHARMACEUTICAL INDUSTRIES | -0.6% | 0.8% | 10.5% |
DIVIS LABORATORIES | 3.1% | 3.8% | 49.2% |
CIPLA | 0.4% | 2.5% | 1.2% |
TORRENT PHARMACEUTICALS | -0.2% | 6.4% | 20.5% |
DR REDDYS LABORATORIES | -0.6% | 3.3% | 0.1% |
MANKIND PHARMA | 1.3% | 0.7% | 10.4% |
ZYDUS LIFESCIENCES | 1.8% | 7.3% | -6.7% |
LUPIN | 1% | 0.7% | 21.7% |
AJANTA PHARMA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 2.12 % |
Y-o-Y | 11.04 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Mar2025 | ₹1,170 Cr | 2.12 | |
Dec2024 | ₹1,146 Cr | -3.41 | |
Sep2024 | ₹1,187 Cr | 3.64 | |
Jun2024 | ₹1,145 Cr | 8.62 | |
Mar2024 | ₹1,054 Cr | -4.62 | |
Dec2023 | ₹1,105 Cr | 7.46 | |
Sep2023 | ₹1,028 Cr | 0.72 | |
Jun2023 | ₹1,021 Cr | - |
AJANTA PHARMA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -7.38 % |
Y-o-Y | 6.77 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Mar2025 | ₹297 Cr | -7.38 | |
Dec2024 | ₹321 Cr | 3.10 | |
Sep2024 | ₹311 Cr | -5.81 | |
Jun2024 | ₹330 Cr | 18.69 | |
Mar2024 | ₹278 Cr | -11.38 | |
Dec2023 | ₹314 Cr | 8.05 | |
Sep2023 | ₹291 Cr | 7.13 | |
Jun2023 | ₹271 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -9.29 % |
Y-o-Y | -3.83 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Mar2025 | 25.39% | -9.29 | |
Dec2024 | 27.99% | 6.75 | |
Sep2024 | 26.22% | -9.12 | |
Jun2024 | 28.85% | 9.28 | |
Mar2024 | 26.4% | -7.11 | |
Dec2023 | 28.42% | 0.57 | |
Sep2023 | 28.26% | 6.36 | |
Jun2023 | 26.57% | - |
AJANTA PHARMA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -3.27 % |
Y-o-Y | 11.12 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Mar2025 | ₹225 Cr | -3.27 | |
Dec2024 | ₹233 Cr | 7.58 | |
Sep2024 | ₹216 Cr | -11.92 | |
Jun2024 | ₹246 Cr | 21.24 | |
Mar2024 | ₹203 Cr | -3.48 | |
Dec2023 | ₹210 Cr | 7.54 | |
Sep2023 | ₹195 Cr | -6.16 | |
Jun2023 | ₹208 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -5.27 % |
Y-o-Y | 0.10 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2025 | 19.25 % | -5.27 | |
Dec2024 | 20.32 % | 11.40 | |
Sep2024 | 18.24 % | -15.04 | |
Jun2024 | 21.47 % | 11.65 | |
Mar2024 | 19.23 % | 1.21 | |
Dec2023 | 19 % | 0.05 | |
Sep2023 | 18.99 % | -6.82 | |
Jun2023 | 20.38 % | - |
AJANTA PHARMA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -3.28 % |
Y-o-Y | 12.03 % |
Quarters | EPS | % Change | |
---|---|---|---|
Mar2025 | ₹17.97 | -3.28 | |
Dec2024 | ₹18.58 | 7.59 | |
Sep2024 | ₹17.27 | -11.93 | |
Jun2024 | ₹19.61 | 22.26 | |
Mar2024 | ₹16.04 | -3.49 | |
Dec2023 | ₹16.62 | 7.50 | |
Sep2023 | ₹15.46 | -6.13 | |
Jun2023 | ₹16.47 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD